Cadrenal Therapeutics (CVKD) Insider Trading & Ownership

$0.43
+0.01 (+2.38%)
(As of 04/26/2024 ET)

Cadrenal Therapeutics (NASDAQ:CVKD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
58.12%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$75,831.70
Number Of
Insiders Selling
(Last 12 Months)
0
Get CVKD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cadrenal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CVKD Insider Buying and Selling by Quarter

Cadrenal Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/4/2023John Raymond MurphyDirectorBuy17,331$0.70$12,131.70  
9/1/2023Quang X PhamCEOBuy70,000$0.91$63,700.00  
(Data available from 1/1/2013 forward)

CVKD Insider Trading Activity - Frequently Asked Questions

Who is on Cadrenal Therapeutics's Insider Roster?

The list of insiders at Cadrenal Therapeutics includes John Raymond Murphy, and Quang X Pham. Learn more on insiders at CVKD.

What percentage of Cadrenal Therapeutics stock is owned by insiders?

58.12% of Cadrenal Therapeutics stock is owned by insiders. Learn more on CVKD's insider holdings.

Which Cadrenal Therapeutics insiders have been buying company stock?

The following insiders have purchased CVKD shares in the last 24 months: John Raymond Murphy ($59,431.70), and Quang X Pham ($63,700.00).

How much insider buying is happening at Cadrenal Therapeutics?

Insiders have purchased a total of 117,331 CVKD shares in the last 24 months for a total of $123,131.70 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CVKD) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners